Valuation: SMAIO

Market Cap 42.81M 49.97M 40.05M 36.66M 68.81M 4.78B 69.72M 473M 185M 2.4B 188M 184M 7.94B P/E 2026 *
-19.5x
P/E 2027 * 190x
Enterprise Value 41.31M 48.22M 38.65M 35.38M 66.4M 4.61B 67.28M 457M 178M 2.32B 181M 177M 7.67B EV / Sales 2026 *
3.76x
EV / Sales 2027 * 2.62x
Free-Float
14.95%
Yield 2026 *
-
Yield 2027 * -
1 day+2.11%
1 week+1.57%
Current month+0.78%
1 month-6.95%
3 months-13.78%
6 months+15.82%
Current year+24.16%
1 week 7.54
Extreme 7.54
7.76
1 month 7.02
Extreme 7.02
8.4
Current year 6
Extreme 6
9.1
1 year 5.9
Extreme 5.9
9.1
3 years 2.25
Extreme 2.25
9.1
5 years 1.9
Extreme 1.9
9.1
10 years 1.9
Extreme 1.9
9.1
Manager TitleAgeSince
Chief Executive Officer - 2008-12-28
Director of Finance/CFO - 2022-05-31
Chief Tech/Sci/R&D Officer - 2020-06-30
Director TitleAgeSince
Chairman - 2021-07-29
Change 5-day change 1-year change 3-year change Capi.($)
+2.11%+1.57%+22.20%+218.03% 50M
+0.88%+6.38%+76.86%+128.23% 1,109B
+1.07%+3.80%+51.03%+61.48% 644B
+1.20%+6.21%+26.47%+76.45% 463B
+1.02%+3.67%+43.14%+47.27% 371B
+0.85%+2.97%+24.48%+42.54% 301B
+1.26%+4.54%+2.20%+14.84% 256B
+1.88%+5.81%+48.54%+68.52% 234B
+1.59%+0.87%-12.95%-51.91% 205B
+1.87%+5.61%+25.81%+92.42% 178B
Average +1.25%+2.65%+30.78%+69.79% 376.11B
Weighted average by Cap. +1.06%+3.26%+44.58%+72.65%

Financials

2026 *2027 *
Net sales 11M 12.84M 10.29M 9.42M 17.68M 1.23B 17.92M 122M 47.42M 617M 48.22M 47.17M 2.04B 16M 18.68M 14.97M 13.7M 25.72M 1.79B 26.06M 177M 68.98M 898M 70.14M 68.61M 2.97B
Net income -2.25M -2.63M -2.11M -1.93M -3.62M -251M -3.66M -24.87M -9.7M -126M -9.86M -9.65M -418M 250K 292K 234K 214K 402K 27.92M 407K 2.76M 1.08M 14.03M 1.1M 1.07M 46.4M
Net Debt -1.5M -1.75M -1.4M -1.28M -2.41M -168M -2.44M -16.58M -6.47M -84.17M -6.58M -6.43M -278M -900K -1.05M -842K -771K -1.45M -101M -1.47M -9.95M -3.88M -50.5M -3.95M -3.86M -167M
Logo SMAIO
S.M.A.I.O « Software, Machines and Adaptive Implants in Orthopaedics » is specialized in the design, manufacture and marketing of implantable medical devices for the treatment of spinal pathologies. The company offers the Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. In addition, S.M.A.I.O has developed the Keops and Balance Analyzer 3D surgical planning and patient database management software, and the company also offers training programs. Net sales break down by source of revenue between sales of products (98.9%) and services (1.1%). Net sales are distributed geographically as follows: France (9.8%), Europe (12.2%), the United States (76.2%), Oceania (1%), Middle East and Africa (0.7%) and Canada (0.1%).
Employees
45
Date Price Change Volume
26-08-21 7.760 +2.11% 447
26-08-20 €7.600 +0.26% 120
26-08-19 €7.580 +0.53% 5
26-08-18 €7.540 0.00% 922
26-08-17 €7.540 -1.31% 1,318
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
7.760EUR
Average target price
8.200EUR
Spread / Average Target
+5.67%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALSMA Stock